A new lung cancer treatment has allowed 36.8% of patients to achieve complete tumour disappearance, compared to the 6.9% rate of the standard post-surgery treatment. In addition, 85% of patients survive two years after receiving chemo-immunotherapy before surgery compared to 63% who receive chemotherapy alone before surgery. The study involved oncologist from ICO Badalona and IGTP researcher, Teresa Morán.
At the IGTP TODAY
Recruitment for the clinical trial TÉSTATE PrEP has started. This clinical trial has been designed by the Centre for Epidemiological Studies on HIV/AIDS in Catalonia (CEEISCAT) to implement a pilot plan for online HIV/STI screening in PrEP users.
The four visits under the "Visita la recerca" (Visit the research) cycle of the Fundació La Marató de TV3 at the Germans Trias i Pujol Research Institute (IGTP) have drawn to a successful close. More than 50 collaborators have had the opportunity to gain insight into various research projects funded through this charitable initiative.
The Catalan Minister Nadal highlights "the uniqueness" of facilities like the Comparative Medicine and Bioimage Centre in the research system that promotes "biomedical innovation"
The Catalan Minister of Research and Universities meets with the management team of the CMCiB, which is one of the strategic projects driven by the Germans Trias i Pujol Research Institute (IGTP).
One of the most commonly practised cardiovascular health interventions, the coronary bypass, could undergo a revolutionary innovation with the joint research carried out by the Blood and Tissue Bank (BST), the Germans Trias i Pujol Research Institute (IGTP) and the Vascular Engineering and Applied Biomedicine Group (GEAB) of the IQS (URL). The three centres are working to develop a vascular graft from donor veins that can be used for bypass surgery to restore blood flow.
An international trial has investigated the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19. The results show that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for. Nearly 4,000 healthcare workers took part in the BRACE trial across 36 sites from five countries, including the Germans Trias Hospital. Researchers from an IGTP tuberculosis research group were involved in the development of the study, which has been published in the New England Journal of Medicine.
A state-of-the-art super-resolution fluorescence confocal microscope, called Abberior Infinity, was installed in the high-level biosafety (NCB3) facility of the Centre for Comparative Medicine and Bioimage (CMCiB). The equipment of this class, unique in the region, is a powerful tool for anyone aiming to perform advanced microscopy studies on fully infectious Level 3 pathogens (HIV, SARS-CoV-2, Monkey Pox, TB etc.) The microscope is available for use by all internal and external users via IGTP Microscopy Platform.
CMCiB participates in the preclinical studies of Rob Surgical's surgical robot, the first one designed and manufactured in Catalonia
The centre reaches a milestone in its track-record by adding the first Good Laboratory Practice study in its portfolio where the tested product at the centre will reach clinical trials in humans in accordance with international Good Clinical Practice.
The new episode of the podcast 'Un bri de ciència' is presented under the title "La diabetis tipus 1: quan la defensa t'ataca" (Type 1 diabetes: when your defences attack you). Researcher Marta Vives Pi explains the problems of autoimmune diseases, with an emphasis on type 1 diabetes.
EATRIS, the European infrastructure for translational medicine, has appointed 7 Expert Centres, to provide high value added services historically offered by EATRIS Coordination and Support. Those expert services that are complementary to the existing laboratory research services offered by EATRIS institutions cover crucial areas such as innovation management, regulatory strategy, translational feasibility, and early health technology assessment. With 7 newly appointed Expert Centres, EATRIS will continue serving Europe's translational research efforts and growing demand for expert services.